PhaseBio to Present at Cowen and Company 40th Annual Health Care Conference
February 26, 2020 16:01 ET
|
PhaseBio Pharmaceuticals, Inc.
MALVERN, Pa. and SAN DIEGO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and...
PhaseBio Appoints Alex C. Sapir to Board of Directors
February 13, 2020 16:01 ET
|
PhaseBio Pharmaceuticals, Inc.
MALVERN, Pa. and SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and...